41
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful pregnancy outcome in a patient with myelofibrosis receiving ruxolitinib treatment in the first trimester

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 16 Dec 2023, Accepted 10 May 2024, Published online: 20 May 2024
 

Acknowledgements

None.

Author contributions

IU, MD, and IP collected and analyzed the data. MD and AEF wrote the manuscript. DB, AEF, and BS critically revised the whole manuscript. IU and IP followed up with the patient and provided their expertise. All authors read and approved the final manuscript.

Consent and complying with ethics

Written informed consent was obtained from the patient. Publishing permission was obtained from the Ethics Committee Board of University of Clinical Center of Vojvodine.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

For original data, please contact [email protected]

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.